Incidence of Cancer Among Patients With Atopic Dermatitis | Allergy and Clinical Immunology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Leung  DYBieber  T Atopic dermatitis  Lancet 2003;361151- 160PubMedGoogle ScholarCrossref
Maughan  WZMuller  SAPerry  HOPittelkow  MRO'Brien  PC Incidence of skin cancers in patients with atopic dermatitis treated with coal tar: a 25-year follow-up study  J Am Acad Dermatol 1980;3612- 615PubMedGoogle ScholarCrossref
Jekler  JDiffey  BLarkö  O Ultraviolet radiation dosimetry in phototherapy for atopic dermatitis  J Am Acad Dermatol 1990;2349- 51PubMedGoogle ScholarCrossref
Ming  MELevy  RHoffstad  O  et al.  The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers  J Am Acad Dermatol 2004;50357- 362PubMedGoogle ScholarCrossref
Buechner  SAWinkelmann  RK Pre-Sezary erythroderma evolving to Sezary syndrome: a report of seven cases  Arch Dermatol 1983;119285- 291PubMedGoogle ScholarCrossref
Abel  EANickoloff  BJShelby  DMWatson  WWood  GS Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis  J Dermatol Surg Oncol 1986;121089- 1093PubMedGoogle ScholarCrossref
Epidemiologiskt Centrum, The Swedish Hospital Discharge Register Available at: May 25, 2004
Epidemiologiskt Centrum, The Cause of Death Register Available at: May 25, 2004
Statistiska Centralbyrån, Total Population Register.  Örebro Statistics Sweden2003;
Lapins  JYe  WNyrén  OEmtestam  L Incidence of cancer among patients with hidradenitis suppurativa  Arch Dermatol 2001;137730- 734PubMedGoogle Scholar
Mattsson  BRutqvist  L-EWallgren  A Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry  Int J Epidemiol 1985;1464- 69PubMedGoogle ScholarCrossref
Bailar  JC  IIIEderer  F Significance factors for the ratio of Poisson variable to its expectation  Biometrics 1964;20639- 643Google ScholarCrossref
Breslow  NEDay  NE The Design and Analysis of Cohort Studies  Lyon, France International Agency for Research on Cancer1987;82
Hanifin  JMRajka  G Diagnostic features of atopic dermatitis  Acta Derm Venereol 1980;92(suppl)44- 47Google Scholar
Rajka  G Essential Aspects of Atopic Dermatitis  Berlin-Heidelberg, Germany Springer-Verlag1989;
Böhme  MSvensson  AKull  INordvall  SLWahlgren  C-F Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study  Acta Derm Venereol 2001;81193- 197PubMedGoogle ScholarCrossref
Robinette  CDFraumeni  JF  Jr Asthma and subsequent mortality in World War II veterans  J Chronic Dis 1978;31619- 624PubMedGoogle ScholarCrossref
Reynolds  PKaplan  GA Asthma and cancer  Am J Epidemiol 1987;125539- 540PubMedGoogle Scholar
Boffetta  PYe  WAdami  HOMucci  LNyrén  O Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden  Br J Cancer 2001;85678- 682PubMedGoogle ScholarCrossref
Vesterinen  EPukkala  ETimonen  TAromaa  A Cancer incidence among 78,000 asthmatic patients  Int J Epidemiol 1993;22976- 982PubMedGoogle ScholarCrossref
Alderson  M Mortality from malignant disease in patients with asthma  Lancet 1974;21475- 1477PubMedGoogle ScholarCrossref
Markowe  HLBulpitt  CJShipley  MJRose  GCrombie  DLFleming  DM Prognosis in adult asthma: a national study  BMJ 1987;295949- 952PubMedGoogle ScholarCrossref
Mills  PKBeeson  WLFraser  GEPhillips  RL Allergy and cancer: organ site-specific results from the Adventist Health Study  Am J Epidemiol 1992;136287- 295PubMedGoogle Scholar
Ye  WChow  WHLagergren  J  et al.  Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma  Br J Cancer 2001;851317- 1321PubMedGoogle ScholarCrossref
Sigurgeirsson  BLindelöf  B Positive patch tests and cancer: an epidemiological study  Am J Contact Dermat 1991;2161- 164Google Scholar
Lindelöf  BSigurgeirsson  BWahlgren  C-FEklund  G Chronic urticaria and cancer: an epidemiological study of 1155 patients  Br J Dermatol 1990;123453- 456PubMedGoogle ScholarCrossref
Smith  JBFenske  NA Cutaneous manifestations and consequences of smoking  J Am Acad Dermatol 1996;34717- 732PubMedGoogle ScholarCrossref
Morren  MAPrzybilla  BBamelis  MHeykants  BReynaers  ADegreef  H Atopic dermatitis: triggering factors  J Am Acad Dermatol 1994;31467- 473PubMedGoogle ScholarCrossref
Mills  CMSrivastava  EDHarvey  IM  et al.  Cigarette smoking is not a risk factor in atopic dermatitis  Int J Dermatol 1994;3333- 34PubMedGoogle ScholarCrossref
September 2005

Incidence of Cancer Among Patients With Atopic Dermatitis

Author Affiliations

Author Affiliations: Department of Medicine, Section of Dermatology and Venereology (Drs Hagströmer and Emtestam), and Department of Medical Epidemiology and Biostatistics (Drs Ye and Nyrén), Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden.

Arch Dermatol. 2005;141(9):1123-1127. doi:10.1001/archderm.141.9.1123

Objective  To assess the risk of skin cancer and other cancers among patients with atopic dermatitis.

Design  Register-based retrospective cohort study.

Setting  Sweden.

Patients  A total of 15 666 hospitalized patients identified in the national Inpatient Register as having discharge diagnoses of atopic dermatitis between January 1, 1965, and December 31, 1999.

Interventions  The National Swedish Cancer Register coded malignant neoplasms during the entire period of study. Follow-up time was calculated from the date of entry in the cohort until the occurrence of a first cancer diagnosis, emigration, death, or the end of the observation period, whichever occurred first.

Main Outcome Measures  Follow-up by means of record linkages to several nationwide registers, among them the National Swedish Cancer Register. Standardized incidence ratios (SIRs) (the ratios of numbers of observed patients with cancer to expected numbers of incident cases of cancer) estimated the risk of developing cancer relative to the risks in the age-, sex-, and calendar year– matched general Swedish population.

Results  After excluding the first year of follow-up, the risk of developing any cancer was increased by 13% (95% confidence interval [CI] of SIR, 1.01-1.25, based on 311 observed patients with cancer). Excess risks were observed for cancers of the esophagus (SIR, 3.5; 95% CI, 1.3-7.7; 6 patients), pancreas (SIR, 1.9; 95% CI, 1.0-3.4; 11 patients), brain (SIR, 1.6; 95% CI, 1.1-2.4; 27 patients), and lung (SIR, 2.0; 95% CI, 1.3-2.8; 31 patients) and for lymphoma (SIR, 2.0; 95% CI, 1.4-2.9; 29 patients). There was a nonsignificant 50% excess risk for nonmelanoma skin cancer (SIR, 1.5; 95% CI, 0.8-2.6; 12 patients), seemingly confined to men and to the first 10 years of follow-up. Malignant melanoma did not occur more often than expected.

Conclusions  The observed risk elevations, all of borderline statistical significance, should be interpreted cautiously. We could not control for possible confounding by cases of cancer caused by smoking, and the combination of multiple significance testing and few observed patients may have generated chance findings.